COOKIES: By using this website you agree that we can place Google Analytics Cookies on your device for performance monitoring. |
University of Cambridge > Talks.cam > Cancer Research UK Cambridge Institute (CRUK CI) Seminars in Cancer > Tumor genomes shed light into somatic mutational processes and cancer vulnerabilities
Tumor genomes shed light into somatic mutational processes and cancer vulnerabilitiesAdd to your list(s) Download to your calendar using vCal
If you have a question about this talk, please contact . Somatic mutations are the driving force of cancer genome evolution. The rate of somatic mutations appears to be greatly variable across the genome due to variations in chromatin organization, DNA accessibility and replication timing. In addition, other variables that influence the mutation rate in a local scale are starting to emerge. I will discuss recent findings from our lab on how genome conformation influences mutation rate. These findings have important implications for our understanding of mutational and DNA repair processes, genome evolution and in the identification of cancer driver mutations. Given the evolutionary principles of cancer, one effective way to identify cancer genes is by tracing the signals left by the positive selection of driver mutations across tumours. Using this concept we analyze thousands of tumor genomes to generate a compendium of cancer genes across tumor types (http://www.intogen.org), and we build machine learning models inspired in evolutionary biology that effectively identify driver mutations in each gene and cancer type (http://www.intogen.org/boostdm). The results (integrated in CancerGenomeInterpreter.org) contribute to the interpretation of tumor mutations in precision cancer medicine. Somatic mutations may also drive clonal expansions in normal tissues, such as clonal hematopoiesis. We have performed a “reverse calling” to reliably identify blood somatic mutations in 12000 cancer patients. Repurposing methods of cancer genomics we identify genes and mutations driving clonal hematopoiesis (http://www.intogen.org/ch). This talk is part of the Cancer Research UK Cambridge Institute (CRUK CI) Seminars in Cancer series. This talk is included in these lists:
Note that ex-directory lists are not shown. |
Other listsPolitical Thought Postdoctoral Forum Churchill College Phoenix Society Creative Research at Museum of Archaeology & AnthropologyOther talksThe ubiquitous acoustic bubble: a brief introduction Communicating Uncertainty in Official Statistics "Image analysis: from particle physics to cancer research" MMV - OFb Microglia and astrocyte involvement in synapse loss in Alzheimer’s disease |